ERAXIS (Roerig)


Welcome to the PulseAid listing for the ERAXIS drug offered from Roerig. This Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Roerig
NON-PROPRIETARY NAME: anidulafungin
SUBSTANCE NAME: ANIDULAFUNGIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-02-17
END MARKETING DATE: 0000-00-00


ERAXIS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionERAXIS from Roerig
LABELER NAME: Roerig
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/15mL)
START MARKETING DATE: 2006-02-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0049-0114_abc8d51a-7bc1-409a-8ae9-f4195cd14d54
PRODUCT NDC: 0049-0114
APPLICATION NUMBER: NDA021632

Other ANIDULAFUNGIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RoerigERAXIS